Cargando…
Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies
AIMS: Invasive cribriform and intraductal carcinoma (IDC) are associated with adverse outcome in prostate cancer patients, with the large cribriform pattern having the worst outcome in radical prostatectomies. Our objective was to determine the impact of the large and small cribriform patterns in pr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321809/ https://www.ncbi.nlm.nih.gov/pubmed/35384019 http://dx.doi.org/10.1111/his.14658 |
_version_ | 1784756139349508096 |
---|---|
author | Rijstenberg, L Lucia Hansum, Tim Kweldam, Charlotte F Kümmerlin, Intan P Remmers, Sebastiaan Roobol, Monique J van Leenders, Geert J L H |
author_facet | Rijstenberg, L Lucia Hansum, Tim Kweldam, Charlotte F Kümmerlin, Intan P Remmers, Sebastiaan Roobol, Monique J van Leenders, Geert J L H |
author_sort | Rijstenberg, L Lucia |
collection | PubMed |
description | AIMS: Invasive cribriform and intraductal carcinoma (IDC) are associated with adverse outcome in prostate cancer patients, with the large cribriform pattern having the worst outcome in radical prostatectomies. Our objective was to determine the impact of the large and small cribriform patterns in prostate cancer biopsies. METHODS AND RESULTS: Pathological revision was carried out on biopsies of 1887 patients from the European Randomised Study of Screening for Prostate Cancer. The large cribriform pattern was defined as having at least twice the size of adjacent benign glands. The median follow‐up time was 13.4 years. Hazard ratios for metastasis‐free survival (MFS) and disease‐specific survival (DSS) were calculated using Cox proportional hazards regression. Any cribriform pattern was found in 280 of 1887 men: 1.1% IDC in grade group (GG) 1, 18.2% in GG2, 57.1% in GG3, 55.4% in GG4 and 59.3% in GG5; the large cribriform pattern was present in 0, 0.5, 9.8, 18.1 and 17.3%, respectively. In multivariable analyses, small and large cribriform patterns were both (P < 0.005) associated with worse MFS [small: hazard ratio (HR) = 3.04, 95% confidence interval (CI) = 1.93–4.78; large: HR = 3.17, 95% CI = 1.68–5.99] and DSS (small: HR = 4.07, 95% CI = 2.51–6.62; large: HR = 4.13, 95% CI = 2.14–7.98). Patients with the large cribriform pattern did not have worse MFS (P = 0.77) or DSS (P = 0.96) than those with the small cribriform pattern. CONCLUSIONS: Both small and large cribriform patterns are associated with worse MFS and DSS in prostate cancer biopsies. Patients with the large cribriform pattern on biopsy have a similar adverse outcome as those with the small cribriform pattern. |
format | Online Article Text |
id | pubmed-9321809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93218092022-07-30 Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies Rijstenberg, L Lucia Hansum, Tim Kweldam, Charlotte F Kümmerlin, Intan P Remmers, Sebastiaan Roobol, Monique J van Leenders, Geert J L H Histopathology Original Articles AIMS: Invasive cribriform and intraductal carcinoma (IDC) are associated with adverse outcome in prostate cancer patients, with the large cribriform pattern having the worst outcome in radical prostatectomies. Our objective was to determine the impact of the large and small cribriform patterns in prostate cancer biopsies. METHODS AND RESULTS: Pathological revision was carried out on biopsies of 1887 patients from the European Randomised Study of Screening for Prostate Cancer. The large cribriform pattern was defined as having at least twice the size of adjacent benign glands. The median follow‐up time was 13.4 years. Hazard ratios for metastasis‐free survival (MFS) and disease‐specific survival (DSS) were calculated using Cox proportional hazards regression. Any cribriform pattern was found in 280 of 1887 men: 1.1% IDC in grade group (GG) 1, 18.2% in GG2, 57.1% in GG3, 55.4% in GG4 and 59.3% in GG5; the large cribriform pattern was present in 0, 0.5, 9.8, 18.1 and 17.3%, respectively. In multivariable analyses, small and large cribriform patterns were both (P < 0.005) associated with worse MFS [small: hazard ratio (HR) = 3.04, 95% confidence interval (CI) = 1.93–4.78; large: HR = 3.17, 95% CI = 1.68–5.99] and DSS (small: HR = 4.07, 95% CI = 2.51–6.62; large: HR = 4.13, 95% CI = 2.14–7.98). Patients with the large cribriform pattern did not have worse MFS (P = 0.77) or DSS (P = 0.96) than those with the small cribriform pattern. CONCLUSIONS: Both small and large cribriform patterns are associated with worse MFS and DSS in prostate cancer biopsies. Patients with the large cribriform pattern on biopsy have a similar adverse outcome as those with the small cribriform pattern. John Wiley and Sons Inc. 2022-05-04 2022-06 /pmc/articles/PMC9321809/ /pubmed/35384019 http://dx.doi.org/10.1111/his.14658 Text en © 2022 The Authors. Histopathology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Rijstenberg, L Lucia Hansum, Tim Kweldam, Charlotte F Kümmerlin, Intan P Remmers, Sebastiaan Roobol, Monique J van Leenders, Geert J L H Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
title | Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
title_full | Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
title_fullStr | Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
title_full_unstemmed | Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
title_short | Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
title_sort | large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321809/ https://www.ncbi.nlm.nih.gov/pubmed/35384019 http://dx.doi.org/10.1111/his.14658 |
work_keys_str_mv | AT rijstenbergllucia largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies AT hansumtim largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies AT kweldamcharlottef largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies AT kummerlinintanp largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies AT remmerssebastiaan largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies AT roobolmoniquej largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies AT vanleendersgeertjlh largeandsmallcribriformarchitecturehavesimilaradverseclinicaloutcomeonprostatecancerbiopsies |